Aryo Bagas Prawira, . (2025) PROFIL NEUROPROTEKTOR PADA PENDERITA STROKE AKUT DI UNIT STROKE RSPAD GATOT SOEBROTO. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.
![[img]](http://repository.upnvj.ac.id/style/images/fileicons/text.png) |
Text
1_Abstrak.pdf Download (220kB) |
|
Text
2_Awal.pdf Download (2MB) |
|
Text
3_Bab 1.pdf Restricted to Repository UPNVJ Only Download (253kB) |
|
Text
4_Bab 2.pdf Restricted to Repository UPNVJ Only Download (831kB) |
|
Text
5_Bab 3.pdf Restricted to Repository UPNVJ Only Download (355kB) |
|
Text
6_Bab 4.pdf Restricted to Repository UPNVJ Only Download (291kB) |
|
Text
7_Bab 5.pdf Download (248kB) |
|
Text
8_Daftar Pustaka.pdf Download (244kB) |
|
Text
9_Riwayat hidup.pdf Restricted to Repository staff only Download (134kB) |
|
Text
10_Lampiran.pdf Restricted to Repository UPNVJ Only Download (925kB) |
|
Text
11_Bebas plagiarisme.pdf Restricted to Repository staff only Download (2MB) |
|
Text
12_Artikel KI.pdf Restricted to Repository staff only Download (371kB) |
Abstract
Objective Stroke is an acute neurological condition caused by impaired cerebral blood flow and remains a major cause of mortality and disability, thus requiring supportive therapies such as neuroprotective agents to reduce neuronal damage. This study aimed to describe the profile of neuroprotective agent use among acute stroke patients in the Stroke Unit of Gatot Soebroto Central Army Hospital, Jakarta Method A descriptive observational study with a cross-sectional design was conducted. Data were obtained from medical records of acute stroke patients and analyzed using univariate analysis to describe patient characteristics and patterns of neuroprotective use Result The results showed that most patients were aged 56–65 years and predominantly male. Ischemic stroke was the most common type observed. Citicoline was the most frequently prescribed neuroprotective agent, while piracetam was used in a smaller proportion of patients. The most common dose of citicoline was 500 mg, whereas piracetam was generally administered at a dose of 1200 mg. Oral administration was the predominant route, with citicoline most commonly given twice daily. Conclusion In conclusion, citicoline was the primary neuroprotective agent used in acute stroke patients in the Stroke Unit, reflecting current clinical practice patterns.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Additional Information: | [No. Panggil : 2210211207] [Pembimbing 1 : Citra Ayu Aprilia] [Pembimbing 2 : Maulidya Ayudika] [Penguji : Erna Harfiani] |
| Uncontrolled Keywords: | acute stroke; citicoline; neuroprotective agent; piracetam |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Fakultas Kedokteran > Program Studi Kedokteran (S1) |
| Depositing User: | ARYO BAGAS PRAWIRA |
| Date Deposited: | 01 Sep 2026 14:15 |
| Last Modified: | 03 Sep 2026 04:41 |
| URI: | http://repository.upnvj.ac.id/id/eprint/41811 |
Actions (login required)
 |
View Item |